Fungal Infections

20 registered clinical trials studyying Fungal Infections — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Fungal Infections During and After the SARS-CoV-2 Pandemic: A Retrospective Comparison NCT06483815	Bekir Sami Uyanık	—
Recruiting	Emergency PWAS in Respiratory Infectious Disease NCT05336851	The University of Hong Kong	—
Unknown	fungalAi for Fungal Surveillance & Antifungal Stewardship NCT03793231	Bayside Health	—
Completed	Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazol NCT02631954	Chong Kun Dang Pharmaceutical	Phase 1
Completed	Genetic Variation and Variability in Posaconazole Pharmacokinetics in Children NCT02358499	Children's Mercy Hospital Kansas City	Phase 1
Completed	MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial NCT02306330	Oxford University Clinical Research Unit, Vietnam	N/A
Completed	Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/ NCT02025699	MeMed Diagnostics Ltd.	—
Completed	A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergill NCT01782131	Merck Sharp & Dohme LLC	Phase 3
Unknown	Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections NCT01105013	Laboratório Teuto Brasileiro S/A	Phase 3
Completed	Safety and Efficacy of Posaconazole Oral Suspension in Usual Practice in Korea (P08547) NCT01436578	Merck Sharp & Dohme LLC	—
Unknown	Registry of Febrile Neutropenia and Invasive Fungal Infections NCT01684189	Chang Gung Memorial Hospital	—
Recruiting	Studies of Disorders With Increased Susceptibility to Fungal Infections NCT01222741	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Pharmacokinetics and Safety of Posaconazole Tablet in Participants at High Risk for Invasive Fungal Infections NCT01777763	Merck Sharp & Dohme LLC	Phase 1
Completed	A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections NCT00794703	Astellas Pharma Inc	Phase 3
Terminated	A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03 NCT01716234	Merck Sharp & Dohme LLC	Phase 1
Completed	A Study of Safety and Pharmacokinetics of Repeated Dose of Micafungin as Antifungal Prophylaxis in Children an NCT00606268	Astellas Pharma Inc	Phase 1
Completed	A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity NCT00353158	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Phase 1
Completed	Interest of Real-time Polymerase Chain Reaction (PCR) in the Diagnosis of Fungal Infections NCT00876096	Centre Hospitalier Universitaire de Nice	N/A
Completed	Pharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome Study NCT00177710	University of Pittsburgh	Phase 3
Completed	Pharmacokinetic Profiles of Inhaled Lipid Complex Amphotericin B (Abelcet ®) NCT00177684	University of Pittsburgh	Phase 3